Adipose type I interferon signalling protects against metabolic dysfunction
Timon E. Adolph(Innsbruck Medical University), Herbert Tilg(Innsbruck Medical University), Barbara Enrich(Innsbruck Medical University), Christoph Grander(Innsbruck Medical University), Verena Wieser(Innsbruck Medical University), Susanne Kaser(Innsbruck Medical University), Felix Grabherr(Innsbruck Medical University), Patrizia Moser(Innsbruck Medical University), Alexander R. Moschen(Innsbruck Medical University)
Cited by 28
Related Papers
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
|Hepatology|2010|2.4k
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
|The Journal of Immunology|2007|915
Inflammatory Mechanisms in the Regulation of Insulin Resistance
|Molecular Medicine|2008|762
Calprotectin: from biomarker to biological function
|Gut|2021|476
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
|Gastroenterology|2022|303